Tricuspid regurgitation stages

Revision as of 13:53, 12 September 2014 by Rim Halaby (talk | contribs) (→‎Stages)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Tricuspid Regurgitation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tricuspid Regurgitation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Stages

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography

Chest X Ray

Electrocardiogram

Cardiac Stress Test

Cardiac MRI

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Tricuspid regurgitation stages On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid regurgitation stages

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onTricuspid regurgitation stages

CDC on Tricuspid regurgitation stages

Tricuspid regurgitation stages in the news

Blogs on Tricuspid regurgitation stages

Directions to Hospitals Treating Tricuspid regurgitation

Risk calculators and risk factors for Tricuspid regurgitation stages

Overview

Stages

Stage Definition Anatomy of the valve Hemodynamics of the valve Hemodynamic changes Symptoms
A At risk Primary TR
  • Mild rheumatic change
  • Mild prolapse
  • Findings related to other conditions (IE, carcinoid, radiation)
  • Presnece of an intra-annular RV pacemaker or ICD lead
  • Cardiac transplant (biopsy related)

Secondary TR

  • No abnomrla findings
  • Beginning of annular dilation
Absent Absent Absent
B Progressive Primary
  • Progressive leaflet deterioration/destruction
  • Moderate-to-severe prolapse and limited chordal rupture

Secondary

  • Beginning of annular dilation
  • Moderate leaflet tethering
Mild TR
  • Central jet area <5.0 cm2
  • Undefined width of vena contracta
  • Soft and parabolic CW jet density and contour
  • Systolic dominance of hepatic vein flow

Moderate TR

  • Central jet area 5–10 cm2
  • Undefined width of vena contracta width but <0.70 cm
  • Dense, variable CW jet density and contour
  • Systolic blunting of hepatic vein flow
Mild TR
  • Normal size of RV/RA/IVC

Moderate TR

  • Absence of RV enlargement
  • Absent or mild RA enlargement
  • Absent or mild IVC enlargement with normal respirophasic variation
  • Normal RA pressure
None
C Asymptomatic severe Primary
  • Flail or grossly distorted leaflets

Secondary

  • Severe annular dilation (>40 mm or 21 mm/m2)
  • Marked leaflet tethering
* Central jet area >10.0 cm2
  • Vena contracta width >0.7 cm
  • Dense, triangular CW jet density and contour with early peak
  • Systolic reversal in hepatic vein flow
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
  • Increased RA pressure with “c-V” wave
  • Possible diastolic interventricular septal flattening
None
D Symptomatic severe Primary
  • Flail or grossly distorted leaflets

Secondary

  • Severe annular dilation (>40 mm or 21 mm/m2)
  • Marked leaflet tethering
* Central jet area >10.0 cm2
  • Vena contracta width >0.7 cm
  • Dense, triangular CW jet density and contour with early peak
  • Systolic reversal in hepatic vein flow
* Dilated RV/RA/IVC and decreased IVC respirophasic variation
  • Increased RA pressure with “c-V” wave
  • Possible diastolic interventricular septal flattening
Presence of symptoms (fatigue, dyspnea, anorexia, edema, abdominal distention, palpitations)

References

Template:WH Template:WS